The FDA-approved indication for left atrial appendage closure (LAAC) devices such as WATCHMAN is limited to patients who:
-
A
Have paroxysmal AF and are anticoagulation-naive
-
B
Have non-valvular AF with elevated stroke risk and long-term anticoagulation contraindications
-
C
Prefer device therapy over medication for personal reasons alone
-
D
Have permanent AF with preserved ejection fraction